| Literature DB >> 27048447 |
Abstract
Nephrologists provide medical care to patients presenting with acute kidney injury, chronic kidney disease, glomerular diseases, and electrolyte or acid-base disorders, and perform lifesaving dialysis therapies and kidney transplantation. This editorial is an attempt to describe how to write a comprehensive, yet succinct, case report in nephrology. The essential elements of a nephrology case report are defined that can serve as a writing aid to the author.Entities:
Mesh:
Year: 2016 PMID: 27048447 PMCID: PMC4822292 DOI: 10.1186/s13256-016-0852-4
Source DB: PubMed Journal: J Med Case Rep ISSN: 1752-1947
Essential elements of a nephrology case report
| Acute kidney injury: |
| ● Serum creatinine (at presentation and at baseline), estimated glomerular filtration rate |
| ● 24-hour urine output (if able to quantify) |
| ● Urine analysis (especially blood and protein in urine) |
| ● Urine microscopy |
| ● Imaging of kidneys (if available) |
| ● Medication review to evaluate for nephrotoxic medications |
| Acute glomerulonephritis/nephrotic syndrome: |
| ● Hypertension |
| ● Systemic symptoms/signs (edema, anasarca, arthritis or rash) |
| ● Urine analysis (especially blood and protein in urine) |
| ● Urine microscopy (specifically presence or absence of dysmorphic red blood cells or casts) |
| ● Urine albumin to creatinine ratio (urine protein to creatinine ratio or 24-hour urine protein) |
| ● Kidney biopsy findings |
| Kidney biopsy: |
| Light microscopy |
| ● Number of glomeruli obtained in biopsy sample |
| ● Proportion of glomeruli affected |
| ● Description of pathological findings (with hematoxylin and eosin or periodic acid–Schiff staining) and any special staining |
| Immunofluorescent microscopy |
| ● Type of immunoglobulin and complement evaluated |
| ● Staining pattern (location) and degree (trace to 3+) |
| Electron microscopy |
| ● Significant findings (helpful if images can be included) |
| Drug therapies in glomerular disorders: |
| ● Specify details on immunosuppression regimen for induction and maintenance, mode of administration (oral or intravenous), dose and frequency |
| ● Include details on evidence of remission or lack of response |
| Dialysis therapy: |
| ● State type of dialysis (intermittent hemodialysis, continuous renal replacement therapy or peritoneal dialysis) |
| ● Type of dialysis access |
| ● Dialysis prescription (frequency, duration, composition and volume of dialysate fluid) and any significant machine settings |
| Electrolyte and acid–base disorder: |
| ● Details of electrolyte disorder at baseline and at presentation |
| ● Appropriate blood and urine tests done to determine cause of electrolyte disorder |
| ● Treatment offered and if this led to correction of the electrolyte disorder |
| Imaging finding: |
| ● Type of study |
| ● Specialized imaging (with or without contrast) and images of the radiological studies: ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) |
| Kidney transplant recipient: |
| ● State reason for kidney failure |
| ● Type of kidney transplant (deceased or living donor) |
| ● Human leukocyte antigen matching |
| ● Timing of transplantation |
| ● Any prior episodes of rejection |
| ● Prescribed immunosuppressants |
| Kidney stone: |
| ● Presenting symptoms |
| ● Imaging studies |
| ● Study of stone composition |
| ● 24-hour urine studies (if any) |
| ● Treatment offered (urological intervention or stone prophylaxis) |
If an element is missing or unavailable, please state the absence of the data as a limitation. This practice assures the editor and reader that every possible attempt was made to obtain the piece of information and demonstrates appropriate thought processes